Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanhua Yue

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Journal of Clinical Oncology|May 10, 2022
Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemiaYang Cao, Yue Liu, Limei Shang, et al.
Leukemia Research|September 16, 2022
Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapyYanhua Yue, Yang Cao, Fei Wang, et al.
Oncology Letters|November 2, 2020
Summed rest score in gated myocardial perfusion imaging is a good predicator for treatment-related cardiotoxicity after anthracycline chemotherapy in patients with diffuse large B-cell lymphomaYan Lin, Jianfeng Wang, Min Xu, et al.
Journal of Immunology Research|March 27, 2023
Vascular Normalization Was Associated with Colorectal Tumor Regression upon Anti-PD-L1 Combinational TherapyYan Zhang, Jiayan Gao, Yan He, et al.
Frontiers in Oncology|August 22, 2022
Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistanceYanhua Yue, Yang Cao, Xunyuan Mao, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Clinical Oncology|May 10, 2022
Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemiaYang Cao, Yue Liu, Limei Shang, et al.
Leukemia Research|September 16, 2022
Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapyYanhua Yue, Yang Cao, Fei Wang, et al.
Oncology Letters|November 2, 2020
Summed rest score in gated myocardial perfusion imaging is a good predicator for treatment-related cardiotoxicity after anthracycline chemotherapy in patients with diffuse large B-cell lymphomaYan Lin, Jianfeng Wang, Min Xu, et al.
Journal of Immunology Research|March 27, 2023
Vascular Normalization Was Associated with Colorectal Tumor Regression upon Anti-PD-L1 Combinational TherapyYan Zhang, Jiayan Gao, Yan He, et al.
Frontiers in Oncology|August 22, 2022
Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistanceYanhua Yue, Yang Cao, Xunyuan Mao, et al.
Pageof 2